Edition:
United States

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

172.04USD
12:18pm EDT
Change (% chg)

$0.21 (+0.12%)
Prev Close
$171.83
Open
$171.90
Day's High
$172.30
Day's Low
$171.29
Volume
78,599
Avg. Vol
417,586
52-wk High
$173.53
52-wk Low
$139.07

Latest Key Developments (Source: Significant Developments)

Thermo Fisher sets quarterly cash dividend of $0.15 per share
Thursday, 18 May 2017 08:30am EDT 

May 18 (Reuters) - Thermo Fisher Scientific Inc :Sets quarterly cash dividend of $0.15per share.  Full Article

Thermo Fisher Scientific signs development agreement with Agios Pharmaceuticals
Thursday, 18 May 2017 08:00am EDT 

May 18 (Reuters) - Thermo Fisher Scientific Inc :Thermo Fisher Scientific signs development agreement with Agios Pharmaceuticals for next-generation sequencing oncology companion diagnostic in cholangiocarcinoma.Thermo Fisher Scientific Co will retain rights to commercialize test globally and will lead necessary filings to seek clearance from regional regulatory agencies.Says under terms of agreement, Thermo Fisher will retain rights to commercialize test globally.Thermo Fisher Scientific says it will also lead all necessary filings to seek clearance from regional regulatory agencies.Thermo Fisher Scientific - upon validation of CDX, it will submit a supplemental premarket approval application to expand clinical claims for its multi-therapy NGS test.  Full Article

DSM announces Thermo Fisher will commence tender offer to acquire all shares of Patheon
Monday, 15 May 2017 07:19am EDT 

May 15 (Reuters) - KONINKLIJKE DSM NV ::INFORMS MARKET ON PATHEON N.V..BOARD OF DIRECTORS OF PATHEON N.V., COMPANY IN WHICH DSM HOLDS APPROXIMATELY 48.7 MILLION ORDINARY SHARES, UNANIMOUSLY APPROVED ACQUISITION OF PATHEON BY THERMO FISHER SCIENTIFIC INC..THERMO FISHER WILL COMMENCE A TENDER OFFER TO ACQUIRE ALL OF THE ISSUED AND OUTSTANDING SHARES OF PATHEON FOR $35.00 PER ORDINARY SHARE IN CASH.ENTERED INTO TENDER AND SUPPORT AGREEMENT WITH THERMO FISHER PURSUANT TO WHICH DSM WILL TENDER ITS SHARES IN TRANSACTION, WHICH IS EXPECTED TO BE COMPLETED BY END OF 2017.  Full Article

Thermo Fisher Scientific to acquire Patheon for a purchase price of about $7.2 bln
Monday, 15 May 2017 07:00am EDT 

May 15 (Reuters) - Thermo Fisher Scientific Inc :Thermo Fisher Scientific to acquire Patheon, a leading contract development and manufacturing organization (CDMO).Thermo Fisher Scientific Inc - transaction represents a purchase price of approximately $7.2 billion.Thermo Fisher Scientific Inc - Thermo Fisher will commence a tender offer to acquire all of issued and outstanding shares of Patheon for $35.00 per share in cash.Thermo fisher scientific inc - deal includes assumption of approximately $2.0 billion of net debt.Thermo Fisher Scientific Inc - transaction represents a purchase price of approximately $7.2 billion.Thermo Fisher Scientific Inc - deal expected to be immediately and significantly accretive to adjusted earnings per share.Thermo Fisher Scientific Inc - expects to realize total synergies of approximately $120 million by year three following close.Thermo Fisher Scientific Inc - Thermo Fisher has obtained committed debt financing from Goldman Sachs Bank USA and Goldman Sachs Lending Partners Llc.Thermo Fisher Scientific Inc - expects to finance purchase price with debt of approximately $5.2 billion and equity of approximately $2 billion.Thermo Fisher Scientific Inc - Patheon will become part of Thermo Fisher's laboratory products and services segment..Thermo Fisher Scientific - transaction is expected to be immediately and significantly accretive to Thermo Fisher's adjusted EPS by $0.30 in first full year after close.  Full Article

Temasek Holdings (Private) Ltd cuts share stake in Thermo Fisher Scientific, Univar
Monday, 15 May 2017 06:26am EDT 

May 15 (Reuters) - Temasek Holdings (Private) Ltd:Temasek Holdings (Private) Ltd cuts share stake in Thermo Fisher Scientific Inc by 44.3 percent to 1.6 million shares.Temasek Holdings (Private) Ltd cuts share stake in Univar Inc by 22.0 percent to 14.2 million shares.Temasek Holdings (Private) Ltd - Change in holdings are as of March 31, 2017 and compared with the previous quarter ended as of Dec 31, 2016.  Full Article

Thermo Fisher said in talks to buy drug ingredient maker Patheon - Bloomberg
Sunday, 14 May 2017 11:09pm EDT 

May 14 (Reuters) - :Thermo Fisher said in talks to buy drug ingredient maker Patheon - Bloomberg.  Full Article

Thermo Fisher Scientific posts Q1 adj earnings of $2.08/share
Wednesday, 26 Apr 2017 06:00am EDT 

April 26 (Reuters) - Thermo Fisher Scientific Inc :Q1 adjusted earnings per share of $2.08.Q1 revenue grew 11 percent to $4.77 billion.Q1 GAAP earnings per share $1.40.Says raising 2017 revenue guidance to range of $19.51 billion to $19.71 billion versus original guidance of $19.38 billion to $19.62 billion.Says raising 2017 adjusted EPS guidance to range of $9.12 to $9.28 versus the $9.06 to $9.24 previously communicated.In the first quarter of 2017, life sciences solutions segment revenue grew 12 percent to $1.36 billion.Q1 earnings per share view $2.02, revenue view $4.68 billion -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $9.17, revenue view $19.53 billion -- Thomson Reuters I/B/E/S.  Full Article

SpeeDx, Thermo Fisher announce partnership for FDA clearance of Molecular Diagnostic
Monday, 24 Apr 2017 08:00am EDT 

April 24 (Reuters) - SpeeDx::SpeeDx and Thermo Fisher Scientific announce strategic partnership for FDA clearance of Molecular Diagnostic.SpeeDx- Signed agreement with Thermo Fisher in support of SpeeDx's plan to submit its ResistancePlus MG test for clearance by U.S. FDA.  Full Article

Thermo Fisher Scientific transferred plastics for cell culture and vaccines to life sciences solutions segment
Monday, 17 Apr 2017 08:01am EDT 

April 17 (Reuters) - Thermo Fisher Scientific Inc :Thermo Fisher Scientific - Effective Jan 1, co transferred its plastics for cell culture and vaccines/biologics to life sciences solutions segment.Thermo Fisher - Also transferred sample preparation and analysis, production chemicals product lines to life sciences solutions segment - sec filing.Thermo Fisher Scientific - Effective Jan 1, transferred biochemical product line from life sciences solutions segment to laboratory products & services.Thermo Fisher Scientific Inc - Effective January 1, 2017, co transferred certain product lines to further align its products and commercial teams.  Full Article

Thermo fisher scientific CEO Marc Casper's total 2016 compensation was $17.8 mln
Tuesday, 4 Apr 2017 08:32am EDT 

Thermo Fisher Scientific Inc :Says ceo Marc Casper's total 2016 compensation was $17.8 million versus $16.3 million in 2015 - SEC filing.  Full Article

More From Around the Web

BRIEF-Patheon says to be obligated to pay Thermo Fisher termination compensation of $203 million in cash

* Patheon NV - under termination of deal in certain circumstances, co to be obligated to pay thermo fisher termination compensation of $203 million in cash Source text for Eikon: (http://bit.ly/2qGr8XK) Further company coverage: